"A 1-year multicenter placebo-controlled study of ALCAR in Alzheimer's disease." Neurology 1996;47(3):705-11
220: 6070 Dippenaar N, Clauss RP, Feinendegen LE
About Amy Sunderman, MS, RD Amy is a registered dietitian, nutritionist and author with over 20 years of experience in the supplement industry
Two-year trends of taxane-induced neuropathy in women enrolled in a randomized trial of acetyl-L-carnitine (SWOG S0715)
KT: Data curation, Writing original draft
Another meta-analysis of four randomized, placebo-controlled trials found evidence of a reduction in fasting plasma glucose concentration and no improvement of glycated hemoglobin concentration in subjects with type 2 diabetes mellitus supplemented with acetyl-L-carnitine (ALCAR) (44)